Blog

Paul Sargos: Must Read – New Paper Challenging a Dogma Published in EUO

Paul Sargos/X

Jun 28, 2025, 13:05

Paul Sargos: Must Read – New Paper Challenging a Dogma Published in EUO

Paul Sargos, Radiation Oncologist, Head of the radiation oncology department at Bergonié Institute, shared a post on X:

“JUST OUT in EUO, New paper challenging a dogma.

MUST READ: Constance Huck has done a great job to show that CIS is not always a contra-indication for Trimodal Therapy in the management of MIBC.

Thanks to all co-authors for their input!”

Title: Radiation Therapy in the Management of Muscle-invasive Bladder Cancer with Carcinoma in Situ: Still a No Go?

Authors: Constance Huck, Vérane Achard, Jason Efstathiou, Julien Van Damme, Alexandre R. Zlotta, Evanguelos Xylinas, Ananya Choudhury, Morgan Rouprêt, Bertrand Tombal, Paul Sargos

Read Full Article.

Paul Sargos

Read OncoDaily’s Special Article: “Bladder Cancer Cure Rate: What Patients Need to Know in 2025”

Bladder Cancer Cure Rate

Alexandre R. Zlotta Ananya Choudhury Bertrand Tombal cancer Constance Huck Evanguelos Xylinas Jason Efstathiou Julien Van Damme Morgan Roupret OncoDaily Oncology Paul Sargos Verane Achard

Marking One Year of Progress in IDH-Mutant Glioma Treatment - Servier Pharmaceuticals

James Whale Dies at 74: The Radio Icon’s Long Fight Against Kidney Cancer

A Pivotal Day for Geron

Top GU Immunotherapy Trials to Watch at ESMO 2025

Julie Gralow Received the 2025 NCG Lifetime Achievement Award in Oncology